![Edwin Naylor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edwin Naylor
Algemeen Directeur bij EnMed MicroAnalytics, Inc.
Actieve functies van Edwin Naylor
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Parabase Genomics, Inc.
![]() Parabase Genomics, Inc. Medical/Nursing ServicesHealth Services Parabase Genomics, Inc. offers neonatal and pediatric diagnostics. The firm offers neonatal care through the development of early diagnostics for actionable inherited disorders. The company was founded by Gabor Bethlendy and Andy Bhattacharjee is headquartered in Boston, MA. | Directeur/Bestuurslid | - | - |
EnMed MicroAnalytics, Inc. | Algemeen Directeur | 01-01-2017 | - |
Oprichter | - | - |
Loopbaan van Edwin Naylor
Eerdere bekende functies van Edwin Naylor
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DiaVacs, Inc.
![]() DiaVacs, Inc. BiotechnologyHealth Technology DiaVacs, Inc. develops and commercializes cell-based therapies for the treatment of type 1 diabetes. The company is based in La Jolla, CA. The company was founded by Dietrich A. Stephan, Nick Giannoukakis, and David L. Finegold. Alan J. Lewis has been the CEO of the company since 2015. | Directeur/Bestuurslid | - | - |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectoraal
Health Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Parabase Genomics, Inc.
![]() Parabase Genomics, Inc. Medical/Nursing ServicesHealth Services Parabase Genomics, Inc. offers neonatal and pediatric diagnostics. The firm offers neonatal care through the development of early diagnostics for actionable inherited disorders. The company was founded by Gabor Bethlendy and Andy Bhattacharjee is headquartered in Boston, MA. | Health Services |
DiaVacs, Inc.
![]() DiaVacs, Inc. BiotechnologyHealth Technology DiaVacs, Inc. develops and commercializes cell-based therapies for the treatment of type 1 diabetes. The company is based in La Jolla, CA. The company was founded by Dietrich A. Stephan, Nick Giannoukakis, and David L. Finegold. Alan J. Lewis has been the CEO of the company since 2015. | Health Technology |
EnMed MicroAnalytics, Inc. |
- Beurs
- Insiders
- Edwin Naylor
- Ervaring